Passage Bio Q4 EPS $(4.09) Misses $(2.68) Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings MissesNews
Passage Bio (NASDAQ:PASG) reported quarterly losses of $(4.09) per share which missed the analyst consensus estimate of $(2.68) by 52.5 percent. This is a 2.25 percent decrease over losses of $(4.00) per share from the
Passage Bio (NASDAQ:PASG) reported quarterly losses of $(4.09) per share which missed the analyst consensus estimate of $(2.68) by 52.5 percent. This is a 2.25 percent decrease over losses of $(4.00) per share from the same period last year.